Literature DB >> 21055817

Retinopathy signs in people without diabetes: the multi-ethnic study of atherosclerosis.

Elvis Ojaimi1, Thanh T Nguyen, Ronald Klein, F M Amirul Islam, Mary Frances Cotch, Barbara E K Klein, Jie-Jin Wang, Tien Yin Wong.   

Abstract

OBJECTIVE: To describe the prevalence of retinopathy and associations with cardiovascular risk factors in persons without diabetes in 4 racial/ethnic groups (white, black, Hispanic, and Chinese).
DESIGN: Population-based, cross-sectional study. PARTICIPANTS: We included 6176 subjects aged 45-84 years without diabetes, selected from 6 United States communities.
METHODS: Fundus images were taken using 45° digital camera through dark-adapted pupils and were graded for retinopathy as defined by the Early Treatment Diabetic Retinopathy Study severity scale: microaneurysms, hemorrhages, cotton wool spots, intraretinal microvascular abnormalities, hard exudates, venous beading, and new vessels. MAIN OUTCOME MEASURES: Retinopathy and the association with cardiovascular risk factors.
RESULTS: Prevalence rates of retinopathy in persons without diabetes were 12.5% overall, varying from 11.9% (white), 13.9% (black), 12.6% (Hispanic), to 17.2% (Chinese). Hypertension was strongly associated with retinopathy (odds ratio [OR], 1.47; 95% confidence interval [CI], 1.23-1.75). After adjusting for age, gender, race, and other parameters, smoking (OR, 1.50; 95% CI, 1.09-2.06) and increased internal carotid intima media thickness (OR, 1.22; 95% CI, 1.05-1.41) were associated with retinopathy. A range of serum inflammatory factors were examined, but none were found to be significant.
CONCLUSIONS: Retinopathy in persons without diabetes is common, varies with race/ethnicity, and associated with cardiovascular risk factors, including hypertension, smoking, and carotid artery intima media thickness.
Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21055817      PMCID: PMC3045651          DOI: 10.1016/j.ophtha.2010.08.007

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  39 in total

1.  Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study.

Authors:  L D Hubbard; R J Brothers; W N King; L X Clegg; R Klein; L S Cooper; A R Sharrett; M D Davis; J Cai
Journal:  Ophthalmology       Date:  1999-12       Impact factor: 12.079

2.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Authors: 
Journal:  Diabetes Care       Date:  1997-07       Impact factor: 19.112

3.  Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study.

Authors:  T Y Wong; R Klein; D J Couper; L S Cooper; E Shahar; L D Hubbard; M R Wofford; A R Sharrett
Journal:  Lancet       Date:  2001-10-06       Impact factor: 79.321

Review 4.  Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality.

Authors:  T Y Wong; R Klein; B E Klein; J M Tielsch; L Hubbard; F J Nieto
Journal:  Surv Ophthalmol       Date:  2001 Jul-Aug       Impact factor: 6.048

5.  Retinopathy in older persons without diabetes and its relationship to hypertension.

Authors:  T Yu; P Mitchell; G Berry; W Li; J J Wang
Journal:  Arch Ophthalmol       Date:  1998-01

6.  Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study.

Authors:  Hendrik A van Leiden; Jacqueline M Dekker; Annette C Moll; Giel Nijpels; Robert J Heine; Lex M Bouter; Coen D A Stehouwer; Bettine C P Polak
Journal:  Diabetes Care       Date:  2002-08       Impact factor: 19.112

7.  Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators.

Authors:  G Howard; A R Sharrett; G Heiss; G W Evans; L E Chambless; W A Riley; G L Burke
Journal:  Stroke       Date:  1993-09       Impact factor: 7.914

8.  Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population.

Authors:  R Klein; B E Klein; S E Moss; Q Wang
Journal:  Arch Ophthalmol       Date:  1994-01

9.  Retinopathy, glucose, and insulin in an elderly population. The Rotterdam Study.

Authors:  R P Stolk; J R Vingerling; P T de Jong; I Dielemans; A Hofman; S W Lamberts; H A Pols; D E Grobbee
Journal:  Diabetes       Date:  1995-01       Impact factor: 9.461

10.  Hypertensive retinopathy in Afro-Caribbeans and Europeans. Prevalence and risk factor relationships.

Authors:  P S Sharp; N Chaturvedi; R Wormald; P M McKeigue; M G Marmot; S M Young
Journal:  Hypertension       Date:  1995-06       Impact factor: 10.190

View more
  10 in total

1.  Impaired coronary and retinal vasomotor function to hyperoxia in Individuals with Type 2 diabetes.

Authors:  Mary E Lott; Julia E Slocomb; Zhaohui Gao; Robert A Gabbay; David Quillen; Thomas W Gardner; Kerstin Bettermann
Journal:  Microvasc Res       Date:  2015-05-20       Impact factor: 3.514

2.  Retinopathy in old persons with and without diabetes mellitus: the Age, Gene/Environment Susceptibility--Reykjavik Study (AGES-R).

Authors:  E Gunnlaugsdottir; S Halldorsdottir; R Klein; G Eiriksdottir; B E Klein; R Benediktsson; T B Harris; L J Launer; T Aspelund; V Gudnason; M F Cotch; F Jonasson
Journal:  Diabetologia       Date:  2011-12-02       Impact factor: 10.122

3.  Retinopathy in non diabetics, diabetic retinopathy and oxidative stress: a new phenotype in Central Africa?

Authors:  Benjamin Longo-Mbenza; Moise Mvitu Muaka; Wayiza Masamba; Lucien Muizila Kini; Igor Longo Phemba; Dalida Kibokela Ndembe; Doris Tulomba Mona
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

4.  Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe).

Authors:  Lucia Sobrin; Todd Green; Xueling Sim; Richard A Jensen; E Shyong Tai; Wan Ting Tay; Jie Jin Wang; Paul Mitchell; Niina Sandholm; Yiyuan Liu; Kustaa Hietala; Sudha K Iyengar; Matthew Brooks; Monika Buraczynska; Natalie Van Zuydam; Albert V Smith; Vilmundur Gudnason; Alex S F Doney; Andrew D Morris; Graham P Leese; Colin N A Palmer; Anand Swaroop; Herman A Taylor; James G Wilson; Alan Penman; Ching J Chen; Per-Henrik Groop; Seang-Mei Saw; Tin Aung; Barbara E Klein; Jerome I Rotter; David S Siscovick; Mary Frances Cotch; Ronald Klein; Mark J Daly; Tien Y Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

Review 5.  Hypertensive eye disease.

Authors:  Carol Y Cheung; Valérie Biousse; Pearse A Keane; Ernesto L Schiffrin; Tien Y Wong
Journal:  Nat Rev Dis Primers       Date:  2022-03-10       Impact factor: 52.329

6.  Prevalence of retinopathy and its risk factors in a Japanese population.

Authors:  Sayaka Fukushima; Tomoko Nakagami; Chikako Suto; Akira Hirose; Yasuko Uchigata
Journal:  J Diabetes Investig       Date:  2013-02-13       Impact factor: 4.232

Review 7.  Retinal arterial hypertrophy: the new LVH?

Authors:  Kaivan Khavandi; Meena Arunakirinathan; Adam S Greenstein; Anthony M Heagerty
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

Review 8.  Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease.

Authors:  William B Horton; Eugene J Barrett
Journal:  Endocr Rev       Date:  2021-01-28       Impact factor: 19.871

9.  Polycystic ovary syndrome: aggressive or protective factor for the retina? Evaluation of macular thickness and retinal nerve fiber layers using high-definition optical coherence tomography.

Authors:  José Edvan de Souza-Júnior; Carlos Alexandre de Amorim Garcia; Elvira Maria Mafaldo Soares; Técia Maria Oliveira Maranhão; Telma Maria Araújo Moura Lemos; George Dantas Azevedo
Journal:  J Ophthalmol       Date:  2015-02-11       Impact factor: 1.909

10.  Association of glucose metabolism and retinopathy signs in non-diabetic individuals in midlife-The Northern Finland Birth Cohort 1966 study.

Authors:  Anni Saunajoki; Juha Auvinen; Ville Saarela; Janne-Joonas Uusitalo; Ilmari Leiviskä; Sirkka Keinänen-Kiukaanniemi; M Johanna Liinamaa; Markku Timonen
Journal:  PLoS One       Date:  2020-10-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.